Lupin Limited has informed the Exchange regarding a press release dated April 23, 2025, titled "Lupin Diagnostics Achieves NABL Accreditation for All Greenfield Labs ".
LUPIN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lupin Limited has shared a press release dated April 23, 2025, announcing that its subsidiary Lupin Diagnostics has received NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditation for all its Greenfield labs. NABL is the premier quality accreditation body in India for medical testing laboratories, and this covers every lab the diagnostics business has set up from scratch. The accreditation signals that these labs meet nationally recognised standards for testing accuracy, equipment calibration, and operational quality. This is a milestone for Lupin Diagnostics as a standalone business unit and reinforces its credibility with hospitals, doctors, and patients.
This is a positive operational update that strengthens the credibility of Lupin's diagnostics arm, which could support faster customer acquisition and partnerships, though it is not a financial event and unlikely to cause an immediate stock price reaction on its own.